About This Study
The purpose of this study is to see how well a combination of meds may treat early Alzheimer's disease. The meds dasatinib and quercetin will be taken together.
Have mild cognitive impairment or Alzheimer's disease. Not using insulin. Not using or taking chemo meds. Must have a reliable study partner available to attend study visits. Must be able to come to the Sticht Center for study visits. Study team will discuss study details with you.
What Activities Are a Part of this Study?
- Informed Consent Review
- Use of Study Treatments or Placebo
- After Study Follow-Up Activities
- Review of Medical History
- Physical Examinations
- Phone Calls and/or Emails
- Study Visits and Consultations
- Surveys/Questionnaires
- Laboratory and Imaging Tests
- Specimen Sample Collection
Age & Gender
- 65 - 100 years old
- All Genders
Language
- This study enrolls English speakers only
Additional Study Information
- Compensation Offered
- No reimbursement offered
Study Locations
- Greater Winston-Salem, NC